Starling Oncology, Inc. - Common Stock, par value $0.0001 per share (STLN)

CUSIP: 68236X100

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 6 signals
Share change
+3,193,777
SEC-reported price per share
$2.04
Indexed holders
44
Value change
+$6,554,810
Number of buys
24
Number of sells
13
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
101,268,340

Security key

68236X100

Report period

Q4 2023

Indexed institutions

44

Top holders

10

Ownership snapshot

Top reported holders of STLN - Starling Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
James E. Flynn
Disclosed value leader
Ravi Yang Sarin
Comparable rows
0/15
Latest evidence
26 Dec 2023
3/4/5 13F Highest disclosed value: $8,830,768 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Ravi Yang Sarin has the largest disclosed position value at $8.83M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Ravi Yang Sarin's linked filing trail.
Disclosed position value Top 5
James E. Flynn $448.3K
DFP Sponsor LLC $5
Ravi Yang Sarin $8.83M
DEERFIELD MANAGEMENT COMPANY, L.P. $4.82M
JOSH ARNOLD INVESTMENT CONSULTANT... $2.68M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
James E. Flynn
3/4/5
Possible Members of 10% Group, 10%+ Owner
—
mixed-class rows
$448,270
7,887,160 shares
mixed-class rows
— 12 Nov 2021
DFP Sponsor LLC
3/4/5
Possible Members of 10% Group, 10%+ Owner
—
mixed-class rows
$5
3,177,583 shares
mixed-class rows
— 12 Nov 2021
Richy Agajanian
3/4/5
10%+ Owner
—
denominator unverified
—
296,075 shares
— 10 Jun 2022
Ravi Yang Sarin
3/4/5
Director
—
denominator unverified
$8,830,768
4,185,198 shares
— 17 Mar 2023
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
mixed-class rows
$4,818,948
4,610,052 shares
mixed-class rows
— 30 Sep 2023
JOSH ARNOLD INVESTMENT CONSULTANT, LLC
13F
Company
13F
—
mixed-class rows
$2,682,340
2,267,513 shares
mixed-class rows
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
44
Shares
18,436,129
Indexed holders
44
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 indexed holders
36
Q4 2023 indexed holders
44
Indexed holder difference
8
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .